Join NAA NYM for an important event to learn about the latest treatment options for individuals on the autism spectrum and so much more! On Wednesday, October 19, 2016, Dr. Michael Elice will join NAA NYM to discuss the causes of autism and the research supporting biomedical treatment.
Michael W. Elice, M.D. is a board certified pediatrician who has treated Autistic Spectrum Disorders, mitochondrial, immune and metabolic dysregulation for the past 10 years. The treatment is based on the theory that autism and related disorders are actually complex neurodevelopmental disorders with genetic, biochemical and immunological origins, thus making these autoimmune disorders the incidence of which has been increasing rapidly over the past 30 years.
As the research in this field advances, Dr. Elice has treated not only the affected children but their siblings, parents and family members who suffer from other genetically based autoimmune disorders. Dr. Elice is on the board of NYFAC -New York Families of Autistic Children, National Autism Association – New York Metro Chapter and MAPS Physician.
He has lectured at MAPS (Medical Academy for Pediatric Special Needs,) Autism Research Institute (formerly Defeat Autism Now!) conferences, Autism One conferences and local SEPTA and school conferences. Dr Elice has participated in TV and web interviews. He has contributed several chapters to “Cutting Edge Therapies in Autism – 2010-2013” editions and has coauthored papers on immune therapy for autism spectrum disorders. Dr. Elice is also certified in Hyperbaric Medicine.
Dr Elice is a graduate of Syracuse University and the Chicago Medical School. He maintains teaching positions at New York University Medical School and the Albert Einstein College of Medicine and has adjunct professorship at North Shore University Hospital, Manhasset, New York and the Cohen Children’s Hospital of the Long Island Jewish Medical Center, New Hyde Park, New York.
Learn more at his website.
NOTE: GLUTEN & DAIRY FREE SNACKS PLUS BEVERAGES WILL BE PROVIDED
